Physician profile
Haley Hendrix
NPI 1073154647
$373.03
in general payments reported to CMS, 2019-2025
10 companies · $95.36 in 2025
The $95.36 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.84 · 2022: $69.97 · 2023: $83.22 · 2024: $36.64 · 2025: $95.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $186.17 | 2021-2023 | Xifaxan |
| Stryker Corporation | $31.88 | 2025 | T2 |
| Baxter Healthcare | $30.56 | 2025 | Tisseel |
| Intercept Pharmaceuticals, INC. | $25.91 | 2023 | Ocaliva |
| Endo USA, INC. | $21.71 | 2024 | Xiaflex |
| Bioventus LLC | $16.58 | 2025 | Exogen Ultrasound Bone Healing System |
| Solventum Corporation | $16.34 | 2025 | V.A.C.Ulta, Prevena |
| Ossur Americas, INC. | $14.93 | 2024 | I-Digits Quantum |
| Dova Pharmaceuticals | $14.80 | 2021 | |
| Sobi, INC | $14.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.